Showing results (91-100 of 125) with videos related to

Sort By:
Pageof 13
Haematologica|November 9, 2023
Targeting hyperactive platelet-derived growth factor receptor-β signaling in T-cell acute lymphoblastic leukemia and lymphomaStien De Coninck, Renate De Smedt, Beatrice Lintermans, et al.
Haematologica|April 2, 2026
First-year results of the International Leukemia/Lymphoma Target Board for pediatric relapsed and refractory hematological malignanciesUri Ilan, Judith M Boer, Maaike Luesink, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2015
Clinical Impact of Additional Cytogenetic Aberrations, cKIT and RAS Mutations, and Treatment Elements in Pediatric t(8;21)-AML: Results From an International Retrospective Study by the International Berlin-Frankfurt-Münster Study GroupKim Klein, Gertjan Kaspers, Christine J Harrison, et al.
Blood|August 29, 2018
Prognostic impact of t(16;21)(p11;q22) and t(16;21)(q24;q22) in pediatric AML: a retrospective study by the I-BFM Study GroupSanne Noort, Martin Zimmermann, Dirk Reinhardt, et al.
Blood|October 17, 2025
Diagnosis and Management of AML in Pediatric Patients: Consensus Recommendations from an International Expert PanelC Michel Zwaan, Sarah K Tasian, Richard Aplenc, et al.
Blood|April 20, 2018
RNA-based FLT3-ITD allelic ratio is associated with outcome and ex vivo response to FLT3 inhibitors in pediatric AMLDavid G J Cucchi, Barbara Denys, Gertjan J L Kaspers, et al.
Nature Medicine|October 3, 2018
Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemiaElena J Orlando, Xia Han, Catherine Tribouley, et al.
Haematologica|July 4, 2015
CD200/BTLA deletions in pediatric precursor B-cell acute lymphoblastic leukemia treated according to the EORTC-CLG 58951 protocolFarzaneh Ghazavi, Emmanuelle Clappier, Tim Lammens, et al.
British Journal of Haematology|April 21, 2018
An effective modestly intensive re-induction regimen with bortezomib in relapsed or refractory paediatric acute lymphoblastic leukaemiaGertjan J L Kaspers, Denise Niewerth, Bram A J Wilhelm, et al.
Haematologica|January 2, 2015
Criteria for evaluating response and outcome in clinical trials for children with juvenile myelomonocytic leukemiaCharlotte M Niemeyer, Mignon L Loh, Annamaria Cseh, et al.
Pageof 13